In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
